# A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

> **NCT02951962** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 60 (estimated)

## Conditions studied

- Hypertension
- Hyperlipidemia

## Interventions

- **DRUG:** Twynsta 80/5mg
- **DRUG:** Crestor 20mg

## Key facts

- **NCT ID:** NCT02951962
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2016-09
- **Final completion:** 2016-09
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02951962

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02951962, "A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02951962. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*